DALLAS--(BUSINESS WIRE)--Latticework Capital Management (“Latticework” or “LCM”), a growth oriented private equity firm focused exclusively on making control equity investments in the healthcare industry, today announced the final closing of LCM Healthcare Fund II (“Fund II”), exceeding the $275 million target with total commitments of $345 million. Fund II added a diverse group of global investors, including leading endowments, family offices, and fund of funds.
“We are incredibly grateful for the support of both new and returning limited partners and look forward to building off the success of our previous funds,” said Kyle Bradford, Managing Partner and co-founder of Latticework. “This is an important milestone for the firm, particularly given the ongoing challenges of the fundraising environment, and we are excited to continue leveraging our expertise and experience to take advantage of the tremendous opportunities in lower middle market healthcare.”
Consistent with its predecessor funds, Fund II will target control investments in lower middle market healthcare companies that are founder led and seeking a partner to accelerate growth. LCM focuses on opportunities in subsectors where the firm can create value through organic growth initiatives and accretive add-on acquisitions, driving value to customers and the overall healthcare ecosystem.
“We have a demonstrated track record of building partnerships with founders and entrepreneurs to grow their businesses both organically and strategically while ensuring we remain aligned with our value creation plans,” said Steve Neumann, Managing Partner and co-founder of Latticework. “The contributions of our partners, strategic advisors and the entire Latticework team remains a critical part of ensuring our collective success.”
With the closing of Fund II, LCM has raised more than $550 million since the Firm’s founding. Over the last nine years, LCM has completed 11 platform transactions and 120 add-on acquisitions to support the portfolio’s growth.
Acalyx Advisors Inc. (“Acalyx”) served as exclusive placement advisor.
Hogan Lovells US LLP served as legal counsel to Latticework.
About LCM
Headquartered in Dallas, TX, Latticework is a growth oriented private equity firm focused exclusively on making control equity investments in the healthcare industry. LCM has completed more than 130 transactions across a diverse array of healthcare subsectors and currently has more than $550 million in assets under management. LCM leverages its more than 100 combined years of healthcare and investing experience, as well as its network of industry executives, to help companies scale and realize their full long-term value. For more information, please visit www.latticeworkcapital.com.
About Acalyx Advisors
Acalyx is a highly selective independent firm specializing in advisory, private placement, and investor relations for leading alternative asset management firms. The firm is led by respected industry veterans whose relationships date back over the last two decades. Since inception, the Acalyx team has collectively engaged in over 40+ fundraises and raised over $28 billion across several strategies, including buyout, special situations, and credit. For additional information, please visit www.acalyx.com.
